2,855
edits
Certificate in Psychedelic Assisted Therapy: Difference between revisions
Certificate in Psychedelic Assisted Therapy (view source)
Revision as of 01:32, 2 September 2022
, 01:32, 2 September 2022no edit summary
mNo edit summary |
mNo edit summary |
||
| Line 3: | Line 3: | ||
</div>'''A Certificate in Psychedelic Assisted Therapy (CPAT), is the result of the successful completion of a Psychedelic Assisted Therapy Course (PATC). PATCs are courses developed by various organisations (see below) in order to teach [[Guided Psychedelic Therapy|guiding clinicians]] best practice techniques when guiding patients prior, during, and following a psychedelic experience.''' | </div>'''A Certificate in Psychedelic Assisted Therapy (CPAT), is the result of the successful completion of a Psychedelic Assisted Therapy Course (PATC). PATCs are courses developed by various organisations (see below) in order to teach [[Guided Psychedelic Therapy|guiding clinicians]] best practice techniques when guiding patients prior, during, and following a psychedelic experience.''' | ||
Numerous studies<ref>'''Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.''' Eduardo Ekman Schenberg. Front Pharmacol. 2018; 9: 733. Published online 2018 Jul 5. doi: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041963/ 10.3389/fphar.2018.00733]. </ref><ref>'''Ethical and legal issues in psychedelic harm reduction and integration therapy'''. Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, Joseph Rhea & Vilmarie Fraguada Narloch. Harm Reduction Journal volume 18, Article number: 40 (2021)</ref> and a systematic review<ref>'''A systematic review of psychedelic-assisted psychotherapy for mental health''': An evaluation of the current wave of research and suggestions for the future. Wheeler, S. W., & Dyer, N. L. (2020). Psychology of Consciousness: Theory, Research, and Practice, 7(3), 279–315. <nowiki>https://doi.org/10.1037/cns0000237</nowiki></ref> have concluded that supportive therapeutic guidance should be considered the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. As there is currently a world wide shortage of psychedelic integration guides<ref>'''MDMA-Therapy Expert Dr. Rick Doblin''': Boston Magazine. Initially published in 2019 accessed on 9th August 2022 via <nowiki>https://www.bostonmagazine.com/health/2019/09/10/rick-doblin/</nowiki></ref>, a wide array of courses have been developed to encourage more people to become guides. Psychedelic Assisted Therapy training guidelines were initially developed in the US<ref>Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Phelps, J. (2017). Journal of Humanistic Psychology, 57(5), 450–487. doi:10.1177/0022167817711304</ref> however, more recently there has been the establishment of an increasing | Numerous studies<ref>'''Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.''' Eduardo Ekman Schenberg. Front Pharmacol. 2018; 9: 733. Published online 2018 Jul 5. doi: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041963/ 10.3389/fphar.2018.00733]. </ref><ref>'''Ethical and legal issues in psychedelic harm reduction and integration therapy'''. Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, Joseph Rhea & Vilmarie Fraguada Narloch. Harm Reduction Journal volume 18, Article number: 40 (2021)</ref> and a systematic review<ref>'''A systematic review of psychedelic-assisted psychotherapy for mental health''': An evaluation of the current wave of research and suggestions for the future. Wheeler, S. W., & Dyer, N. L. (2020). Psychology of Consciousness: Theory, Research, and Practice, 7(3), 279–315. <nowiki>https://doi.org/10.1037/cns0000237</nowiki></ref> have concluded that supportive therapeutic guidance should be considered the standard of care in the majority of uses of [[Psychedelics|psychedelic medications]] for the treatment of psychiatric disorders. As there is currently a world wide shortage of psychedelic integration guides<ref>'''MDMA-Therapy Expert Dr. Rick Doblin''': Boston Magazine. Initially published in 2019 accessed on 9th August 2022 via <nowiki>https://www.bostonmagazine.com/health/2019/09/10/rick-doblin/</nowiki></ref>, a wide array of courses have been developed to encourage more people to become guides. Psychedelic Assisted Therapy training guidelines were initially developed in the US<ref>Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Phelps, J. (2017). Journal of Humanistic Psychology, 57(5), 450–487. doi:10.1177/0022167817711304</ref> however, more recently there has been the establishment of an increasing number of courses worldwide, these include: | ||
* '''[https://cybin.com/embark/ Embark]''' - Canadian / US proprietary training created by Cybin ltd first released in June 2022<ref>'''Models of Psychedelic-Assisted Psychotherapy''': A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. William Brennan and Alexander B. Belser. Cybin, Inc., Toronto, ON, Canada and Fordham University, New York City, NY, United States. Front. Psychol., 02 June 2022 <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>. | * '''[https://cybin.com/embark/ Embark]''' - Canadian / US proprietary training created by Cybin ltd first released in June 2022<ref>'''Models of Psychedelic-Assisted Psychotherapy''': A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. William Brennan and Alexander B. Belser. Cybin, Inc., Toronto, ON, Canada and Fordham University, New York City, NY, United States. Front. Psychol., 02 June 2022 <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>. | ||
| Line 12: | Line 12: | ||
*'''[https://www.scptr.org/psychedelic-therapy-training-program- SCPTR]''' - ''Salt City Psychedelic Therapy & Research'' is to educate and train. This 8-week live virtual program. | *'''[https://www.scptr.org/psychedelic-therapy-training-program- SCPTR]''' - ''Salt City Psychedelic Therapy & Research'' is to educate and train. This 8-week live virtual program. | ||
In late 2022, a multidisciplinary healthcare team convened consisting of psychotherapists, psychiatrists, neuropsychopharmacologists and mental health nurses to review the content of the courses listed above. It was found whilst the content was satisfactory (see summary of analysis below) that the financial incentives behind the creation of such a course biased the content of the course itself. For example, many of the courses offered above were been created on the basis that the practitioner works within a structured clinical pathway which would require the use of proprietary medicines. As a result, to remove this potential for bias the multidisciplinary group created the world's first [[Open Source Psychedelic-Assisted Therapy]] (OSPAT) which is available for anyone to use, free of charge. | |||
== CPAT Content == | == CPAT Content == | ||